Acasti Pharma (ACST) Reports Q2 Loss of $0.10
Tweet
Share
E-mailGet Alerts ACST Hot Sheet
Join SI Premium – FREE
Acasti Pharma (NASDAQ: ACST) reported Q2 EPS of ($0.10).
For earnings history and earnings-related data on Acasti Pharma (ACST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor
- UBS Reiterates Buy Rating on Dutch Bros Inc. (BROS): 'One of Strongest Growth Stories in Restaurants'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
